Jessica B. Long

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 17 papers. Top paper: “Trends in Breast Cancer Screening Costs Among Privately Insured Women Aged 40 to 64 Years”.

Trends in Breast Cancer Screening Costs Among Privately Insured Women Aged 40 to 64 Years

JAMA Internal Medicine(2021)10.1001/jamainternmed.2021.4832

N/A

0DataRank · unranked

9 citations

Jessica B. Long, Natalia Kunst, Kelly A. Kyanko, Xiao Xu, Susan H. Busch +2 more

Comparative Effectiveness of Digital Breast Tomosynthesis and Mammography in Older Women

Journal of General Internal Medicine(2021)10.1007/s11606-021-07132-6

N/A

0DataRank · unranked

7 citations

Jessica B. Long, Jenerius A. Aminawung, Kelly A. Kyanko, Natalia Kunst, Xiao Xu +4 more

Insurance Coverage Mandates and the Adoption of Digital Breast Tomosynthesis

JAMA Network Open(2022)10.1001/jamanetworkopen.2022.4208

N/A

0DataRank · unranked

13 citations

Jessica B. Long, Kelly A. Kyanko, Xiao Xu, Cary P. Gross, Susan H. Busch +1 more

The role of lung cancer risk and comorbidity in lung cancer screening use

Preventive Medicine Reports(2022)10.1016/j.pmedr.2022.102006

N/A

0DataRank · unranked

4 citations

Jessica B. Long, Hermine Poghosyan, Polly Sather, Cary P. Gross, Ilana B. Richman

Estimating Breast Cancer Overdiagnosis After Screening Mammography Among Older Women in the United States

Annals of Internal Medicine(2023)10.7326/m23-0133

N/A

0DataRank · unranked

57 citations

Jessica B. Long, Pamela R. Soulos, Shi‐Yi Wang, Cary P. Gross, Ilana B. Richman

Disparities in immune and targeted therapy utilization for older US patients with metastatic renal cell carcinoma

JNCI Cancer Spectrum(2023)10.1093/jncics/pkad036

N/A

0DataRank · unranked

12 citations

Jessica B. Long, Sirad Hassan, Stephanie B. Wheeler, Lisa P. Spees, Michael Leapman +5 more

Use of surveillance mammography among older patients with a history of breast cancer

Journal of Geriatric Oncology(2023)10.1016/j.jgo.2023.101686

N/A

0DataRank · unranked

1 citations

Jessica B. Long, Meera Sheffrin, Meghan Lindsay, Ilana B. Richman, Elizabeth R. Berger

Total and treatment-related costs of care associated with in patients with metastatic renal cell carcinoma receiving targeted or immune therapy.

JCO Oncology Practice(2023)10.1200/op.2023.19.11_suppl.28

N/A

0DataRank · unranked

2 citations

Jessica B. Long, Sarah J. Westvold, Stephanie B. Wheeler, Lisa P. Spees, Michael Leapman +5 more

Evolution of systemic therapy from 2015 to 2019 for older patients in the United States with metastatic renal cell carcinoma.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.6_suppl.610

N/A

0DataRank · unranked

0 citations

Jessica B. Long, Sirad Hassan, Stephanie B. Wheeler, Lisa P. Spees, Michael Leapman +5 more

Area Vulnerability and Disparities in Therapy for Patients With Metastatic Renal Cell Carcinoma

JAMA Network Open(2024)10.1001/jamanetworkopen.2024.8747

N/A

0DataRank · unranked

3 citations

Jessica B. Long, Sarah J. Westvold, Michael Leapman, Lisa P. Spees, Michael E. Hurwitz +5 more

Trends in use of intensive care during hospitalizations at the end‐of‐life among older adults with advanced cancer

Journal of the American Geriatrics Society(2024)10.1111/jgs.19119

N/A

0DataRank · unranked

3 citations

Jessica B. Long, Vinay Rao, Anica C. Law, Allan J. Walkey, Elizabeth Pršić +4 more

Cost trends of metastatic renal cell carcinoma therapy: the impact of oral anticancer agents and immunotherapy

JNCI Cancer Spectrum(2024)10.1093/jncics/pkae067

N/A

0DataRank · unranked

1 citations

Jessica B. Long, Sarah J. Westvold, Khushi Agnish, Hannah D. McManus, Michael Leapman +6 more

Cost-Effectiveness and Evidence Gaps Surrounding PSMA-PET for Recurrent Prostate Cancer Evaluation

JAMA Network Open(2025)10.1001/jamanetworkopen.2025.39250

N/A

0DataRank · unranked

3 citations

Jessica B. Long, Preston C. Sprenkle, Isaac Yi Kim, Lawrence Saperstein, Maximilian Rabil +7 more

Feasibility of Using Point-of-Care Biomarkers of Secretory Activation to Address Early, Unplanned Weaning Among Healthy, Term Dyads in Community Settings: A Pilot Study

Breastfeeding Medicine(2025)10.1089/bfm.2024.0374

N/A

0DataRank · unranked

2 citations

Jessica B. Long, R. Moyeda Martinez, Sandra Cárdenas, EM Ryan, Katie T. Kivlighan

Diagnostic yield of surveillance mammography among older women

JNCI Journal of the National Cancer Institute(2025)10.1093/jnci/djaf270

N/A

0DataRank · unranked

1 citations

Meghan Lindsay, Jessica B. Long, Eliza Epstein, Meera Sheffrin, Elizabeth R. Berger +1 more

Off-Label Use of First-Line Immunotherapy for Metastatic Renal Cell Carcinoma

Clinical Genitourinary Cancer(2025)10.1016/j.clgc.2025.102330

N/A

0DataRank · unranked

0 citations

Jessica B. Long, Sarah J. Westvold, Michael Leapman, Michael E. Hurwitz, Aaron Philip Mitchell +4 more

Use of targeted therapy in patients with advanced non-small cell lung cancer in response to broad genomic profiling.

Journal of Clinical Oncology(2025)10.1200/jco.2025.43.16_suppl.11155

N/A

0DataRank · unranked

0 citations

Jessica B. Long, John Rothen, Sida Huang, Pamela R. Soulos, Timothy J. Robinson +9 more